Redirected Auto T Cells for Advanced Myeloma
NCT01352286
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
25
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Myeloma
Interventions
GENETIC:
Autologous Genetically modified T cells
Sponsor
GlaxoSmithKline